Cardiovascular Disease in Adults with Type 1 Diabetes: Looking Beyond Glycemic Control

Rachel G Miller1, Tina Costacou2

  • 1Department of Epidemiology, School of Public Health, University of Pittsburgh, 130 N. Bellefield Avenue, Pittsburgh, PA, 15213, USA.

Insights

People with type 1 diabetes face higher cardiovascular disease (CVD) risks. Beyond blood sugar control, factors like insulin resistance and inflammation significantly impact CVD risk in type 1 diabetes.

Area of Science:

  • Endocrinology
  • Cardiology
  • Metabolic Diseases

Background:

  • Type 1 diabetes (T1D) is associated with elevated cardiovascular disease (CVD) risk, even with improved glycemic control.
  • Current understanding of CVD risk in T1D is incomplete, necessitating exploration beyond glycemia.

Purpose of the Study:

  • To review the interplay between glycemia and CVD risk in adults with T1D.
  • To summarize evidence on non-glycemic factors contributing to excess CVD risk in T1D.
  • To identify gaps and future directions for CVD prevention in T1D.

Main Methods:

  • Literature review focusing on studies examining CVD risk factors in type 1 diabetes.
  • Synthesis of evidence on established and emerging risk factors beyond glycemic control.
  • Analysis of current guidelines and their limitations for CVD prevention in T1D.

Main Results:

  • Glycemic control alone does not fully account for the increased CVD risk in type 1 diabetes.
  • Factors such as insulin resistance, weight gain, sex differences, genetics, and inflammation play significant roles.
  • Emerging risk markers including lipid subclasses and epigenetic modifications warrant further investigation.
  • Lack of T1D-specific guidelines for lipids, blood pressure, and physical activity hinders optimal CVD prevention.

Conclusions:

  • Optimal CVD risk management in type 1 diabetes requires addressing factors beyond glycemic control.
  • Novel markers and precision medicine approaches show promise for improved CVD prediction.
  • Development and implementation of T1D-specific guidelines are crucial for effective CVD prevention.
Abstract

Related Concept Videos

Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
668
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.7K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.0K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
344
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.2K
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
11.5K